Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7521)
All Articles published online
|
Publishing Process of This Article
|
May 15, 2014 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen WX, Ren LH, Shi RH. Implication of miRNAs for inflammatory bowel disease treatment: Systematic review. World J Gastrointest Pathophysiol 2014; 5(2): 63-70 [PMID: 24891977 DOI: 10.4291/wjgp.v5.i2.63] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v5/i2/63.htm |
| Number | Citing Articles |
| 1 |
Anna Wajda, Joanna Łapczuk-Romańska, Agnieszka Paradowska-Gorycka. Epigenetic Regulations of AhR in the Aspect of Immunomodulation. International Journal of Molecular Sciences 2020; 21(17): 6404 doi: 10.3390/ijms21176404
|
| 2 |
Linghao Cai, Dengming Lai, Jiafang Gao, Hao Wu, Bo Shi, Haosen Ji, Jinfa Tou. The role and mechanisms of miRNA in neonatal necrotizing enterocolitis. Frontiers in Pediatrics 2022; 10 doi: 10.3389/fped.2022.1053965
|
| 3 |
Ping Wang, Yan Chen, La-Mei Zhang, Si-Qi Yuan, Shen-Ao Lu, Ying-Jian Zhang. Effect of MicroRNA145 on the multidrug resistance gene of ulcerative colitis in rats. Life Sciences 2021; 278: 119603 doi: 10.1016/j.lfs.2021.119603
|
| 4 |
Soheila Moein, Mostafa Vaghari‐Tabari, Durdi Qujeq, Maryam Majidinia, Seyed Mohammad Nabavi, Bahman Yousefi. MiRNAs and inflammatory bowel disease: An interesting new story. Journal of Cellular Physiology 2019; 234(4): 3277 doi: 10.1002/jcp.27173
|
| 5 |
Yuhua Tian, Jiuzhi Xu, Yuan Li, Ran Zhao, Sujuan Du, Cong Lv, Wei Wu, Ruiqi Liu, Xiaole Sheng, Yongli Song, Xueyun Bi, Guilin Li, Mengzhen Li, Xi Wu, Pengbo Lou, Huiwen You, Wei Cui, Jinyue Sun, Jianwei Shuai, Fazheng Ren, Bing Zhang, Mingzhou Guo, Xiaohua Hou, Kaichun Wu, Lixiang Xue, Hongquan Zhang, Maksim V. Plikus, Yingzi Cong, Christopher J. Lengner, Zhanju Liu, Zhengquan Yu. MicroRNA-31 Reduces Inflammatory Signaling and Promotes Regeneration in Colon Epithelium, and Delivery of Mimics in Microspheres Reduces Colitis in Mice. Gastroenterology 2019; 156(8): 2281 doi: 10.1053/j.gastro.2019.02.023
|
| 6 |
Supaporn Suttamanatwong. MicroRNAs in bone development and their diagnostic and therapeutic potentials in osteoporosis. Connective Tissue Research 2017; 58(1): 90 doi: 10.3109/03008207.2016.1139580
|
| 7 |
Eirini Zacharopoulou, Maria Gazouli, Maria Tzouvala, Antonios Vezakis, George Karamanolis. The contribution of long non-coding RNAs in Inflammatory Bowel Diseases. Digestive and Liver Disease 2017; 49(10): 1067 doi: 10.1016/j.dld.2017.08.003
|
| 8 |
Maria Pierdomenico, Vincenzo Cesi, Salvatore Cucchiara, Roberta Vitali, Enrica Prete, Manuela Costanzo, Marina Aloi, Salvatore Oliva, Laura Stronati. NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016; 22(2): 315 doi: 10.1097/MIB.0000000000000659
|
| 9 |
Bijun Wen, Tomas Tokar, Amel Taibi, Jianmin Chen, Igor Jurisica, Elena M. Comelli. Citrobacter rodentium alters the mouse colonic miRNome. Genes & Immunity 2019; 20(3): 207 doi: 10.1038/s41435-018-0026-z
|
| 10 |
Xiaotong Hu, Shuiping Liu. Handbook of Epigenetics. 2017; : 277 doi: 10.1016/B978-0-12-805388-1.00018-3
|
| 11 |
Alba Rodríguez‐Nogales, Francesca Algieri, Jose Garrido‐Mesa, Teresa Vezza, M. Pilar Utrilla, Natalia Chueca, Federico Garcia, Mónica Olivares, M. Elena Rodríguez‐Cabezas, Julio Gálvez. Differential intestinal anti‐inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition. Molecular Nutrition & Food Research 2017; 61(11) doi: 10.1002/mnfr.201700144
|
| 12 |
Katarzyna Nazimek. The complex functions of microRNA-150 in allergy, autoimmunity and immune tolerance. AIMS Allergy and Immunology 2021; 5(4): 195 doi: 10.3934/Allergy.2021016
|
| 13 |
Inés Moret-Tatay, Marisa Iborra, Elena Cerrillo, Luis Tortosa, Pilar Nos, Belén Beltrán, Ganesh Halade. Possible Biomarkers in Blood for Crohn’s Disease: Oxidative Stress and MicroRNAs—Current Evidences and Further Aspects to Unravel. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/2325162
|
| 14 |
Jie Zhao, Honggang Wang, Jin Zhou, Jun Qian, Haojun Yang, Yan Zhou, Hao Ding, Yu Gong, Xiaoyang Qi, Yuwen Jiao, Pu Ying, Liming Tang, Ye Sun, Weiming Zhu. miR-130a-3p, a Preclinical Therapeutic Target for Crohn’s Disease. Journal of Crohn's and Colitis 2021; 15(4): 647 doi: 10.1093/ecco-jcc/jjaa204
|
| 15 |
Hye‐Youn Kim, Hyeok Yi Kwon, Huyen Trang Ha Thi, Ho Jae Lee, Gwang Il Kim, Ki‐Baek Hahm, Suntaek Hong. MicroRNA‐132 and microRNA‐223 control positive feedback circuit by regulating FOXO3a in inflammatory bowel disease. Journal of Gastroenterology and Hepatology 2016; 31(10): 1727 doi: 10.1111/jgh.13321
|
| 16 |
Zhongyi Li, Yao Wang, Yi Zhu. Association of miRNA-146a rs2910164 and miRNA-196 rs11614913 polymorphisms in patients with ulcerative colitis. Medicine 2018; 97(39): e12294 doi: 10.1097/MD.0000000000012294
|
| 17 |
Surajit Pathak, Alessia Rosaria Grillo, Melania Scarpa, Paola Brun, Renata D'Incà, Laura Nai, Antara Banerjee, Donatella Cavallo, Luisa Barzon, Giorgio Palù, Giacomo Carlo Sturniolo, Andrea Buda, Ignazio Castagliuolo. MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis. Experimental & Molecular Medicine 2015; 47(5): e164 doi: 10.1038/emm.2015.21
|
| 18 |
Yan Huang, Zhe Ma, Yun-hua Cui, Hong-sheng Dong, Ji-meng Zhao, Chuan-zi Dou, Hui-rong Liu, Jing Li, Huan-gan Wu, Ke Ren. Effects of Herb‐Partitioned Moxibustion on the miRNA Expression Profiles in Colon from Rats with DSS‐Induced Ulcerative Colitis. Evidence-Based Complementary and Alternative Medicine 2017; 2017(1) doi: 10.1155/2017/1767301
|
| 19 |
Hui Chen, Lichun Zeng, Wei Zheng, Xiaoli Li, Baixing Lin. Increased Expression of microRNA-141-3p Improves Necrotizing Enterocolitis of Neonates Through Targeting MNX1. Frontiers in Pediatrics 2020; 8 doi: 10.3389/fped.2020.00385
|
| 20 |
Nóra Judit Béres, Zoltán Kiss, Zsófia Sztupinszki, Gábor Lendvai, András Arató, Erna Sziksz, Ádám Vannay, Attila J. Szabó, Katalin Eszter Müller, Áron Cseh, Kriszta Boros, Gábor Veres. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease. Digestive and Liver Disease 2017; 49(4): 378 doi: 10.1016/j.dld.2016.12.022
|
| 21 |
H Jiang, J Shen, Z Ran. Epithelial–mesenchymal transition in Crohn's disease. Mucosal Immunology 2018; 11(2): 294 doi: 10.1038/mi.2017.107
|
| 22 |
Jian Wang, Huaqiang Liu, Lin Tian, Fachen Wang, Liangbo Han, Wei Zhang, Yun-an Bai. miR-15b Inhibits the Progression of Glioblastoma Cells Through Targeting Insulin-like Growth Factor Receptor 1. Hormones and Cancer 2017; 8(1): 49 doi: 10.1007/s12672-016-0276-z
|
| 23 |
Inés Moret-Tatay, Elena Cerrillo, David Hervás, Marisa Iborra, Esteban Sáez-González, Javier Forment, Luis Tortosa, Pilar Nos, Jose Gadea, Belén Beltrán. Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications. Clinical and Translational Gastroenterology 2021; 12(10): e00416 doi: 10.14309/ctg.0000000000000416
|
| 24 |
Wentao Li, Wenqiao Zang, Pei Liu, Yuanyuan Wang, Yuwen Du, Xiaonan Chen, Meng Deng, Wencong Sun, Lei Wang, Guoqiang Zhao, Baoping Zhai. MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer. Tumor Biology 2014; 35(11): 10897 doi: 10.1007/s13277-014-2402-2
|
| 25 |
Alexandros Ο. Konstantinidis, Dimitra Pardali, Katerina K. Adamama-Moraitou, Maria Gazouli, Chrysostomos I. Dovas, Evangelia Legaki, Georgia D. Brellou, Ioannis Savvas, Albert E. Jergens, Timoleon S. Rallis, Karin Allenspach. Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease. BMC Veterinary Research 2020; 16(1) doi: 10.1186/s12917-020-02287-6
|
| 26 |
Priyanka Mishra, Divya Singh, Lilly Ganju, Bhuvnesh Kumar. MicroRNA in gastrointestinal cell signalling. Inflammopharmacology 2018; 26(1): 1 doi: 10.1007/s10787-017-0414-4
|
| 27 |
Yuchun Li, Yuxian Wu. MiR-200-3p inhibits tumor cell proliferation and induces apoptosis by upregulation of FOXO1 in osteosarcoma cells. Molecular & Cellular Toxicology 2018; 14(1): 73 doi: 10.1007/s13273-018-0009-1
|
| 28 |
Milad Bastami, Andrea Masotti, Zahra Saadatian, Abdolreza Daraei, Mojtaba Farjam, Ali Ghanbariasad, Sepideh Zununi Vahed, Shirin Eyvazi, Yaser Mansoori, Ziba Nariman-Saleh-Fam. Critical roles of microRNA-196 in normal physiology and non-malignant diseases: Diagnostic and therapeutic implications. Experimental and Molecular Pathology 2021; 122: 104664 doi: 10.1016/j.yexmp.2021.104664
|
| 29 |
Humaira Rashid, Towfida J. Siddiqua, Biplob Hossain, Abdullah Siddique, Mamun Kabir, Zannatun Noor, Masud Alam, Mamun Ahmed, Rashidul Haque. MicroRNA Expression and Intestinal Permeability in Children Living in a Slum Area of Bangladesh. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.765301
|
| 30 |
Mohammad Elahimanesh, Mohammad Najafi. Cross talk between bacterial and human gene networks enriched using ncRNAs in IBD disease. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-34780-x
|
| 31 |
Nóra J. Béres, Dolóresz Szabó, Dorottya Kocsis, Dániel Szűcs, Zoltán Kiss, Katalin E. Müller, Gábor Lendvai, András Kiss, András Arató, Erna Sziksz, Ádám Vannay, Attila J. Szabó, Gábor Veres. Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016; 22(2): 327 doi: 10.1097/MIB.0000000000000687
|
| 32 |
Yufei Hu, Yifan Lu, Yi Fang, Qizhe Zhang, Zhuoqun Zheng, Xiaojuan Zheng, Xiaohua Ye, Yanping Chen, Jin Ding, Jianfeng Yang. Role of long non-coding RNA in inflammatory bowel disease. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1406538
|
| 33 |
Abdou ElSharawy, Christian Röder, Thomas Becker, Jens K. Habermann, Stefan Schreiber, Philip Rosenstiel, Holger Kalthoff. Concentration of circulating miRNA-containing particles in serum enhances miRNA detection and reflects CRC tissue-related deregulations. Oncotarget 2016; 7(46): 75353 doi: 10.18632/oncotarget.12205
|
| 34 |
Lihui Lin, Gaoshi Zhou, Peng Chen, Ying Wang, Jing Han, Minhu Chen, Yao He, Shenghong Zhang. Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?. Cell Death & Disease 2020; 11(6) doi: 10.1038/s41419-020-2657-z
|
| 35 |
Guanqun Chao, Yingying Wang, Fangxu Ye, Shuo Zhang. Regulation of Colonic Mucosal MicroRNA Expression via Multiple Targets in Visceral Hypersensitivity Rats by Tongxieyaofang. Yonsei Medical Journal 2018; 59(8): 945 doi: 10.3349/ymj.2018.59.8.945
|
| 36 |
Nataliia Nikolaieva, Aneta Sevcikova, Radoslav Omelka, Monika Martiniakova, Michal Mego, Sona Ciernikova. Gut Microbiota–MicroRNA Interactions in Intestinal Homeostasis and Cancer Development. Microorganisms 2022; 11(1): 107 doi: 10.3390/microorganisms11010107
|
| 37 |
Ruiyan Wang, Yanjie Ma, Dan Yu, Jiang Zhao, Peilong Ma. miR-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ETS1. Biomedicine & Pharmacotherapy 2015; 70: 64 doi: 10.1016/j.biopha.2015.01.012
|
| 38 |
Xunru Huang, Yijuan Lin, Xueyan Zheng, Chengdang Wang. MiRNA-338-5p reduced inflammation through TXNIP/NLRP3 inflammasome axis by CXCR4 in DSS-induced colitis. Molecular & Cellular Toxicology 2020; 16(2): 149 doi: 10.1007/s13273-019-00060-x
|
| 39 |
Simon R. Whiteoak, Richard Felwick, Tilman Sanchez-Elsner, J. R. Fraser Cummings. MicroRNAs in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 2015; 21(5): 1160 doi: 10.1097/MIB.0000000000000288
|
| 40 |
Lorenza Putignani, Federica Del Chierico, Pamela Vernocchi, Michele Cicala, Salvatore Cucchiara, Bruno Dallapiccola. Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood–Adulthood Transition. Inflammatory Bowel Diseases 2016; 22(2): 487 doi: 10.1097/MIB.0000000000000602
|
| 41 |
Wenjiong Hao, Wei Luo, Mangmang Bai, Jian Li, Xiaobin Bai, Jie Guo, Jinsong Wu, Maode Wang. MicroRNA-206 Inhibited the Progression of Glioblastoma Through BCL-2. Journal of Molecular Neuroscience 2016; 60(4): 531 doi: 10.1007/s12031-016-0824-6
|
| 42 |
Eugenia Becker, Susan Bengs, Sirisha Aluri, Lennart Opitz, Kirstin Atrott, Claudia Stanzel, Pedro A. Ruiz Castro, Gerhard Rogler, Isabelle Frey-Wagner. Doxycycline, metronidazole and isotretinoin: Do they modify microRNA/mRNA expression profiles and function in murine T-cells?. Scientific Reports 2016; 6(1) doi: 10.1038/srep37082
|
| 43 |
Weiyun Wu, Yanting He, Xiao Feng, Shicai Ye, Hao Wang, Wenkai Tan, Caiyuan Yu, Juxiang Hu, Rong Zheng, Yu Zhou. MicroRNA-206 is involved in the pathogenesis of ulcerative colitis via regulation of adenosine A3 receptor. Oncotarget 2017; 8(1): 705 doi: 10.18632/oncotarget.13525
|
| 44 |
Moaed E. Al-Gazally, Ramsha Khan, Muhammad Imran, Andrés Alexis Ramírez-Coronel, Shadia Hamoud Alshahrani, Farag M.A. Altalbawy, Abduladheem Turki Jalil, Rosario Mireya Romero-Parra, Rahman S. Zabibah, Muhammad Shahid Iqbal, Sajad Karampoor, Rasoul Mirzaei. The role and mechanism of action of microRNA-122 in cancer: Focusing on the liver. International Immunopharmacology 2023; 123: 110713 doi: 10.1016/j.intimp.2023.110713
|
| 45 |
F Chu, Y Hu, Y Zhou, M Guo, J Lu, W Zheng, H Xu, J Zhao, L Xu. MicroRNA-126 deficiency enhanced the activation and function of CD4+T cells by elevating IRS-1 pathway. Clinical and Experimental Immunology 2018; 191(2): 166 doi: 10.1111/cei.13067
|
| 46 |
Jaslin P. James, Lene Buhl Riis, Mikkel Malham, Estrid Høgdall, Ebbe Langholz, Boye S Nielsen. MicroRNA Biomarkers in IBD—Differential Diagnosis and Prediction of Colitis-Associated Cancer. International Journal of Molecular Sciences 2020; 21(21): 7893 doi: 10.3390/ijms21217893
|
| 47 |
Huanxin Zhang, Shizhen Xue, Yi Feng, Jun Shen, Jixian Zhao. MicroRNA‑24‑3p inhibition prevents cell growth of vascular smooth muscle cells by targeting Bcl‑2‑like protein 11. Experimental and Therapeutic Medicine 2020; doi: 10.3892/etm.2020.8517
|
| 48 |
Xin-ya Duan, Yang Sun, Zhu-fen Zhao, Yao-qing Shi, Xun-yan Ma, Li Tao, Ming-wei Liu. Baicalin attenuates LPS-induced alveolar type II epithelial cell A549 injury by attenuation of the FSTL1 signaling pathway via increasing miR-200b-3p expression. Innate Immunity 2021; 27(4): 294 doi: 10.1177/17534259211013887
|
| 49 |
Daniela Elena Serban. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy. Nutrition in Clinical Practice 2015; 30(6): 760 doi: 10.1177/0884533615606898
|
| 50 |
Yoshitaro Shindo, Shoichi Hazama, Yusuke Nakamura, Yuka Inoue, Shinsuke Kanekiyo, Nobuaki Suzuki, Hiroko Takenouchi, Ryouichi Tsunedomi, Masao Nakajima, Tomio Ueno, Shigeru Takeda, Shigefumi Yoshino, Kiyotaka Okuno, Yusuke Fujita, Yoshihiko Hamamoto, Yutaka Kawakami, Masaaki Oka, Hiroaki Nagano. miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancer. Oncology Letters 2017; 14(2): 1355 doi: 10.3892/ol.2017.6303
|
| 51 |
Daqiong Jiang, Huiyan Wang, Zhuyan Li, Zhen Li, Xin Chen, Hongbing Cai. MiR-142 inhibits the development of cervical cancer by targeting HMGB1. Oncotarget 2017; 8(3): 4001 doi: 10.18632/oncotarget.13136
|
| 52 |
Wei Zhou, Haiyin Zhang, Yibin Pan, Yanwu Xu, Yongqing Cao. circRNA expression profiling of colon tissue from mesalazine-treated mouse of inflammatory bowel disease reveals an important circRNA-miRNA-mRNA pathway. Aging 2021; 13(7): 10187 doi: 10.18632/aging.202780
|
| 53 |
Geoffrey W. Krissansen, Yi Yang, Fiona M. McQueen, Euphemia Leung, Deborah Peek, Yih Chih Chan, Cristin Print, Nicola Dalbeth, Megan Williams, Alan G. Fraser. Overexpression of miR-595 and miR-1246 in the Sera of Patients with Active Forms of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2015; 21(3): 520 doi: 10.1097/MIB.0000000000000285
|
| 54 |
Esteban Sáez‐González, Inés Moret‐Tatay, Guillermo Bastida, Mariam Aguas, Marisa Iborra, Pilar Nos, Belén Beltrán. MicroRNA and granulocyte‐monocyte adsorption apheresis combotherapy after inadequate response to anti‐TNF agents in ulcerative colitis. Journal of Clinical Apheresis 2024; 39(1) doi: 10.1002/jca.22101
|
| 55 |
Vinay Kumar, Workineh Torben, Joshua Mansfield, Xavier Alvarez, Curtis Vande Stouwe, Jian Li, Siddappa N. Byrareddy, Peter J. Didier, Bapi Pahar, Patricia E. Molina, Mahesh Mohan. Cannabinoid Attenuation of Intestinal Inflammation in Chronic SIV-Infected Rhesus Macaques Involves T Cell Modulation and Differential Expression of Micro-RNAs and Pro-inflammatory Genes. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00914
|
| 56 |
Weitao Hu, Taiyong Fang, Xiaoqing Chen. Identification of Differentially Expressed Genes and miRNAs for Ulcerative Colitis Using Bioinformatics Analysis. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.914384
|
| 57 |
Xing Liu, Yongguang Zhang, Peng Jiang, Jiachen Cai, Qiuhong Fu, Xiaolei Li, Zhou Li. Ultrasonic cardiogram and MiRNA-21 analysis of cardiac dysfunction in patients with cardiac arrest following cardiopulmonary resuscitation. Computer Methods and Programs in Biomedicine 2020; 190: 105284 doi: 10.1016/j.cmpb.2019.105284
|
| 58 |
Yujie Shen, Min Zhou, Junkai Yan, Zizhen Gong, Yongtao Xiao, Cong Zhang, Peng Du, Yingwei Chen. miR-200b inhibits TNF-α-induced IL-8 secretion and tight junction disruption of intestinal epithelial cells in vitro. American Journal of Physiology-Gastrointestinal and Liver Physiology 2017; 312(2): G123 doi: 10.1152/ajpgi.00316.2016
|
| 59 |
Neha Datta, Charlotte Johnson, Dina Kao, Pratik Gurnani, Cameron Alexander, Christos Polytarchou, Tanya M. Monaghan. MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis. Pharmacological Research 2023; 194: 106870 doi: 10.1016/j.phrs.2023.106870
|
| 60 |
Edda Russo, Lorenzo Cinci, Leandro Di Gloria, Simone Baldi, Mario D’Ambrosio, Giulia Nannini, Elisabetta Bigagli, Lavinia Curini, Marco Pallecchi, Donato Andrea Arcese, Stefano Scaringi, Cecilia Malentacchi, Gianluca Bartolucci, Matteo Ramazzotti, Cristina Luceri, Amedeo Amedei, Francesco Giudici. Crohn’s disease recurrence updates: first surgery vs. surgical relapse patients display different profiles of ileal microbiota and systemic microbial-associated inflammatory factors. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.886468
|
| 61 |
|
| 62 |
Mehdi Zobeiri, Saeideh Momtaz, Fatemeh Parvizi, Devesh Tewari, Mohammad H. Farzaei, Seyed M. Nabavi. Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases. Current Pharmaceutical Biotechnology 2020; 21(13): 1342 doi: 10.2174/1389201021666191216122555
|
| 63 |
Yongjian Xiong, Liqiang Shi, Liang Wang, Zijuan Zhou, Chenou Wang, Yuan Lin, Dong Luo, Juanjuan Qiu, Dapeng Chen. Activation of sirtuin 1 by catalpol-induced down-regulation of microRNA-132 attenuates endoplasmic reticulum stress in colitis. Pharmacological Research 2017; 123: 73 doi: 10.1016/j.phrs.2017.05.030
|
| 64 |
Lingling Guo, Yongsheng Zhang, Lifeng Zhang, Fengbo Huang, Jinfan Li, Shouli Wang. MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancer. Tumor Biology 2016; 37(1): 115 doi: 10.1007/s13277-015-4374-2
|
| 65 |
Matthias Hübenthal, Georg Hemmrich-Stanisak, Frauke Degenhardt, Silke Szymczak, Zhipei Du, Abdou Elsharawy, Andreas Keller, Stefan Schreiber, Andre Franke, Mathias Chamaillard. Sparse Modeling Reveals miRNA Signatures for Diagnostics of Inflammatory Bowel Disease. PLOS ONE 2015; 10(10): e0140155 doi: 10.1371/journal.pone.0140155
|
| 66 |
Raheleh Heydari, Padideh Karimi, Anna Meyfour. Long non-coding RNAs as pathophysiological regulators, therapeutic targets and novel extracellular vesicle biomarkers for the diagnosis of inflammatory bowel disease. Biomedicine & Pharmacotherapy 2024; 176: 116868 doi: 10.1016/j.biopha.2024.116868
|
| 67 |
Carlos D Minacapelli, Manisha Bajpai, Xin Geng, James Van Gurp, Elizabeth Poplin, Peter S Amenta, Steven R Brant, Kiron M Das. miR-206 as a Biomarker for Response to Mesalamine Treatment in Ulcerative Colitis. Inflammatory Bowel Diseases 2019; 25(1): 78 doi: 10.1093/ibd/izy279
|
| 68 |
Reza Yarani, Ali Shojaeian, Oana Palasca, Nadezhda T. Doncheva, Lars Juhl Jensen, Jan Gorodkin, Flemming Pociot. Differentially Expressed miRNAs in Ulcerative Colitis and Crohn’s Disease. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.865777
|
| 69 |
Farnaz Farsi, Nasser Ebrahimi-Daryani, Fereshteh Golab, Abolfazl Akbari, Leila Janani, Mohammad Yahya Karimi, Pardis Irandoost, Naimeh Mesri Alamdari, Shahram Agah, Mohammadreza Vafa. RETRACTED ARTICLE: A randomized controlled trial on the coloprotective effect of coenzyme Q10 on immune-inflammatory cytokines, oxidative status, antimicrobial peptides, and microRNA-146a expression in patients with mild-to-moderate ulcerative colitis. European Journal of Nutrition 2021; 60(6): 3397 doi: 10.1007/s00394-021-02514-2
|
| 70 |
Wen-Juan Tang, Kai-Yue Peng, Zi-Fei Tang, Yu-Huan Wang, Ai-Juan Xue, Ying Huang. MicroRNA-15a - cell division cycle 42 signaling pathway in pathogenesis of pediatric inflammatory bowel disease. World Journal of Gastroenterology 2018; 24(46): 5234-5245 doi: 10.3748/wjg.v24.i46.5234
|